Real‐World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2–6 With Cystic Fibrosis
These real-world findings support the safety and effectiveness of ETI in ycwCF. Robust, long-term studies involving larger populations are essential to confirm these results.
Authors
- Sharon Sarah Cahanovitc
- Adi Dagan
- D. Prais
- Michal Gur
- Mohamad Hadhud
- Ori Efrati
- Ronen Bar‐Yoseph
- Malena Cohen‐Cymberknoh
Institutions
- Hadassah Medical Center (IL)
- Schneider Children's Medical Center (IL)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
- Edmond and Lily Safra Children's Hospital (IL)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/ppul.71523
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00